KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Thermo Fisher Scientific's Cash from Operations rose 337.03% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 billion, marking a year-over-year decrease of 1592.31%. This contributed to the annual value of $8.7 billion for FY2024, which is 310.49% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Cash from Operations is $2.2 billion, which was up 337.03% from $1.4 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Cash from Operations' 5-year high stood at $3.7 billion during Q4 2023, with a 5-year trough of $723.0 million in Q1 2025.
  • In the last 5 years, Thermo Fisher Scientific's Cash from Operations had a median value of $2.2 billion in 2024 and averaged $2.1 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Cash from Operations skyrocketed by 45561.8% in 2021, and later crashed by 6689.37% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Cash from Operations (Quarter) stood at $2.5 billion in 2021, then soared by 41.92% to $3.5 billion in 2022, then rose by 6.77% to $3.7 billion in 2023, then decreased by 11.63% to $3.3 billion in 2024, then tumbled by 31.95% to $2.2 billion in 2025.
  • Its Cash from Operations was $2.2 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $723.0 million in Q1 2025.